Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of Low‐Density Lipoprotein Cholesterol‐Lowering Efficacy for Atorvastatin in a Population‐Based DNA Biorepository

16 Sept 2008

Abstract excerpt

The Marshfield Clinic Personalized Medicine Research Project (PMRP) represents a large population-based biobank located in central Wisconsin. To position the PMRP database for large-scale pharmacogenetic association studies in the context of lipid-lowering therapy, we constructed an electronic phenotyping algorithm to quantify exposure and dose-response for atorvastatin, the most commonly prescribed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lipoproteins and Cardiovascular Health
Share to Pharmacogenetics and Drug Metabolism
Share to Statistical Methods in Clinical Trials

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18834356
DOI: 10.1111/j.1742-7843.2008.00291.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of Low‐Density Lipoprotein Cholesterol‐Lowering Efficacy for Atorvastatin in a Population‐Based DNA BiorepositoryPMID 18834356Read ↗

Characterization of statin dose response in electronic medical records.Semantic proximity Read ↗

Laboratory Medicine in the Clinical Decision Support for Treatment of Hypercholesterolemia: Pharmacogenetics of Statins.Semantic proximity Read ↗

Clinical implications of pharmacogenomics of statin treatmentSemantic proximity Read ↗

Leveraging large-scale biobank EHRs to enhance pharmacogenetics of cardiometabolic disease medicationsSemantic proximity Read ↗

Biobank Scale Pharmacogenomics Informs the Genetic Underpinnings of Simvastatin Use.Semantic proximity Read ↗

Population pharmacogenomics: impact on public health and drug development.Semantic proximity Read ↗

Quantification of the clinical modifiers impacting high-density lipoprotein cholesterol in the community: Personalized Medicine Research Project.Semantic proximity Read ↗

<i>LPA</i> and <i>APOE</i> are associated with statin selection in the UK BiobankSemantic proximity Read ↗

Pharmacogenomics of cholesterol-lowering therapy.Semantic proximity Read ↗

Pharmacogenetics of Lipid-Lowering Agents: Precision or Indecision Medicine?Semantic proximity Read ↗

Pharmacogenomics of statin response.Semantic proximity Read ↗

Genome-wide association of lipid-lowering response to statins in combined study populations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.